Login / Signup

Baseline angiopoietin-2 and FGF19 levels predict treatment response in patients receiving multikinase inhibitors for hepatocellular carcinoma.

Taku ShigesawaGoki SudaMegumi KimuraTomoe ShimazakiOsamu MaeharaRen YamadaTakashi KitagatayaKazuharu SuzukiAkihisa NakamuraMasatsugu OharaMachiko UmemuraNaoki KawagishiMasato NakaiTakuya ShoMitsuteru NatsuizakaKenichi MorikawaKoji OgawaNaoya Sakamoto
Published in: JGH open : an open access journal of gastroenterology and hepatology (2020)
This study is, to our knowledge, the first to demonstrate that baseline ANG2 and FGF19 levels may aid in selecting optimal systemic therapy for patients with unresectable HCC.
Keyphrases
  • healthcare
  • angiotensin ii
  • squamous cell carcinoma
  • radiation therapy
  • liver metastases